BiotechTube

Relapsed Refractory Multiple Myeloma

2 competing products in clinical development for Relapsed Refractory Multiple Myeloma.

Pipeline by Phase

Phase 11
Phase 1/21

All Products (2)

ProductCompanyStageStatusHype
Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomideEli LillyPhase 1/2Completed
41
agenT-797MiNK TherapeuticsPhase 1Completed
25